Educational Activity March 15, 2007

Comparing Safety and Tolerability of Antipsychotic Treatment

John W. Newcomer, MD; Jeffrey A. Lieberman, MD, Chair

J Clin Psychiatry 2007;68(3):e07

This CME activity is expired. For more CME activities, visit CMEInstitute.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders


Article Abstract

Certain modifiable risk factors for diabetes andcardiovascular disease need to be considered when prescribing antipsychoticmedications. Antipsychotics may change a patient’s weight, glucose,cholesterol, and triglycerides. These changes may lead to changes incardiopulmonary health. If switching medications is not a viable option, themetabolic and cardiopulmonary risks may be minimized by monitoring certainbehaviors such as smoking, exercise, diet, and medication adherence. Theprincipals of primary prevention suggest the importance of lowering risk fordisease by using monitoring and intervention approaches.

This CME activity is expired. For more CME activities, visit cme.psychiatrist.com.
Find more articles on this and other psychiatry and CNS topics:
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

Continue Reading...

Did you know members enjoy unlimited free PDF downloads as part of their subscription? Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.

Subscribe Now

Already a member? Login